Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16435
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLiégeois, Frédérique J-
dc.contributor.authorHildebrand, Michael S-
dc.contributor.authorBonthrone, Alexandra-
dc.contributor.authorTurner, Samantha J-
dc.contributor.authorScheffer, Ingrid E-
dc.contributor.authorBahlo, Melanie-
dc.contributor.authorConnelly, Alan-
dc.contributor.authorMorgan, Angela T-
dc.date2016-10-13-
dc.date.accessioned2016-11-21T05:40:43Z-
dc.date.available2016-11-21T05:40:43Z-
dc.date.issued2016-10-13-
dc.identifier.citationScientific Reports 2016; 6: 35192en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16435-
dc.description.abstractFOXP2 is the major gene associated with severe, persistent, developmental speech and language disorders. While studies in the original family in which a FOXP2 mutation was found showed volume reduction and reduced activation in core language and speech networks, there have been no imaging studies of different FOXP2 mutations. We conducted a multimodal MRI study in an eight-year-old boy (A-II) with a de novo FOXP2 intragenic deletion. A-II showed marked bilateral volume reductions in the hippocampus, thalamus, globus pallidus, and caudate nucleus compared with 26 control males (effect sizes from −1 to −3). He showed no detectable functional MRI activity when repeating nonsense words. The hippocampus is implicated for the first time in FOXP2 diseases. We conclude that FOXP2 anomaly is either directly or indirectly associated with atypical development of widespread subcortical networks early in life.en_US
dc.titleEarly neuroimaging markers of FOXP2 intragenic deletionen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleScientific Reportsen_US
dc.identifier.affiliationUCL Institute of Child Health, London, UKen_US
dc.identifier.affiliationGreat Ormond Street Hospital for Children NHS Trust, London, UKen_US
dc.identifier.affiliationThe University of Melbourne, Parkville, Victoria, Australiaen_US
dc.identifier.affiliationFlorey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationAustin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationMurdoch Childrens Research Institute, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationThe Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationRoyal Children’s Hospital, Parkville, Victoria, Australiaen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/27734906en_US
dc.identifier.doi10.1038/srep35192en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-2311-2174en_US
dc.identifier.orcid0000-0001-5132-0774en_US
dc.type.austinJournal Articleen_US
local.name.researcherHildebrand, Michael S
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptEpilepsy Research Centre-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptEpilepsy Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Nov 26, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.